Lanthio Pharma Raises €4.8 Million In Series A, Enters MorphoSys Pact
This article was originally published in The Pink Sheet Daily
Executive Summary
Dutch biotech Lanthio Pharma has entered into an alliance with MorphoSys to develop its lantipeptide technology, with the German drug-discovery company also participating in Lanthio Pharma’s Series A funding round.